Q2 Dealmaking Statistics: Medtech And Diagnostics M&A And Alliance Activity, April-June 2021

During the second quarter of 2021, device company M&A values reached $2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $4.4bn.

Qstats Image 1

The second quarter featured 14 device merger and acqusition transactions, four of which had disclosed values that together totaled $2bn, versus the first quarter, when 24 deals totaled $10.2bn.

The top device M&A deal of the second quarter was Tecan Group AG’s definitive agreement to acquire Paramit (a privately held OEM developer and manufacturer of medical devices and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business